Evidence for activation of cyclooxygenase-1/-2 by endogenous nitric oxide in adjuvant arthritic Lewis rats

Advances in Experimental Medicine and Biology

Volumn 416, Issue , 1997, Pages 343-348

  Thierse, Hermann Josef ^a,b   Friebe, Walter Gunar ^a   Scheuer, Werner ^a   Voelter, Wolfgang ^b   Tibes, Ulrich ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NITRIC OXIDE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALIA;

EID: 0030935395     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (18)

1. 2 inhibitors. Int.Arch.Allergy Immunol. 107.432-134 (1995).
2. 2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Arthritis Rheum. 37.653-661 (1994).
3. H. Kaurr and B. Halliwell, Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. FEBS 350.9-12. (1994).
4. A. Ialenti, S. Moncada, and M. Di Rosa, Modulation of adjuvant arthritis by endogenous nitric oxide. Br.J.Pharmacol. 110.701-706. (1993).
5. X. Wei, I.G. Charles, A. Smith, J. Ure, G.-j. Feng, F.-p. Huang, D. Xu, W. Muller, S. Moncada, and F.Y Liew, Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375.408-411. (1995).
6. J.D. MacMicking, C. Nathan, G. Horn, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q. Xie, K. Sokol, N. Hutchinson, H. Chen, and J.S. Mudgett, Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81.641-650. (1995).
7. A.J. Farrell, D.R. Blake, R.M.J. Palmer, and S. Moncada, Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51.1219-1222. (1992).
8. D.R. Janero and C. Burghardt, Solid-phase extraction on silica cartridges as an aid to platelet-activating factor enrichment and analysis. J Chromatogr. 526.11-24. (1990).
9. D.J. Hanahan and S.T. Weintraub, Platelet-Activating Factor Isolation, Identification, and Assay, Methods of Biochem. Anal. 31.195-219. (1985).
10. M. Lepoivre, H. Boudbid, and J.-F. Petit, Antiproliferative activity of g-Interferon combined with lipopolysaccharide on murine adenocarcinoma: dependence on an L- arginine metabolism with production of nitrite and citrulline. Cancer Res. 49.1970-1976. (1989).
11. 2 in monocytic cell lines. Functional and biochemical aspects of membrane association. Biochem. J. 276.631-636. (1991).
12. L.W. Tjoelker, C. Wilder, C. Eberhardt, D.M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H.L. Trong, L.S. Cousens, G.A. Zimmerman, Y. Yamada, T.M. McIntyre, S.M. Prescott, and P.W. Gray, Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374.549-553. (1995).
13. D. Salvemini, T.P. Misko, J.L. Masferrer, K. Seibert, M.G. Currie, and P. Needleman, Nitric oxide activates cyclooxgenase enzymes. Proc. Natl. Acad. Sci. USA 90.7240-7244. (1993).
14. D. Salvemini, P.T. Manning, B.S. Zweifel, K. Seibert, J. Connor, M.G. Currie, P. Needleman, and J.L. Masferrer, Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96.301 (1995).
15. H.-J. Thierse, W. Scheuer, A. Krusch, G.-W. Friebe, P. Gierschick, and U. Tibes, Major role of cPLA2, secondary of COX and NOS, minor roles of sPLA2 and PLC in experimental inflammation. Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury: 4th Intern. Conf. Hongkong. 42. (1995).
16. J.R. Vane, J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall and D.A. Willoughby, Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91.2046-2050 (1994).
17. I. Wicks, G. McColl, and L. Harrison, New perspectives on rheumatoid arthritis. Immunol. Today 15.553-556 (1994).
18. J.R. Connor, P.T. Manning S.L. Settle, W.M. Moore G.M. Jerome, R.K. Webber, F. Siong Tjoeng, and M.G. Currie, Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273.15-24 (1995).